Risperidone-Associated Extrapyramidal Symptoms

Introduction to EPS

Risperidone can cause acute dystonia, characterized by sudden spastic contractions of muscle groups, often affecting the neck, eyes, or torso, which can be distressing and potentially life-threatening in cases of laryngospasm 1
Risperidone can cause parkinsonism, symptoms including bradykinesia, tremors, and rigidity that mimic Parkinson's disease 1
Risperidone can cause akathisia, a sense of severe restlessness often manifesting as pacing or physical agitation, commonly misinterpreted as psychotic agitation or anxiety 1
Risperidone can cause tardive dyskinesia, an involuntary movement disorder consisting of athetoid or choreic movements, typically in the orofacial region but potentially affecting any part of the body 1

The American Academy of Child and Adolescent Psychiatry notes that risperidone at doses above 2 mg per day has an increased risk of EPS compared to lower doses 2
Risperidone has minimal effect on QT prolongation (0-5 ms) compared to other antipsychotics, which may be relevant when considering overall safety profile 3

Regular monitoring for EPS is essential, with the Abnormal Involuntary Movement Scale (AIMS) recommended at least every 3-6 months after starting therapy 1, 2
For acute EPS management, consider dose reduction when clinically feasible, and anticholinergic medications are helpful for dystonia and parkinsonism 1
Beta-blockers and benzodiazepines may provide relief for akathisia, and prophylactic antiparkinsonian agents may be considered in high-risk patients 1

First-generation antipsychotics, such as haloperidol and droperidol, cause more extrapyramidal symptoms (EPS) but less sedation, while low-potency agents like chlorpromazine cause more sedation with fewer EPS, according to the American Academy of Pediatrics 5

Younger patients have an elevated risk for acute dystonia, and pediatric patients may be at higher risk overall, as reported by the American Academy of Child and Adolescent Psychiatry 6

Before attributing symptoms to medication, it is essential to exclude physical illnesses that can cause similar presentations, such as neurological disorders, metabolic disturbances, structural brain lesions, as noted by the Journal of the American Academy of Child and Adolescent Psychiatry 6
Substance intoxication or withdrawal, particularly anticholinergic or sympathomimetic agents, should also be considered, as antipsychotics can worsen agitation in these contexts, according to the American College of Emergency Physicians 7